Literature DB >> 29628152

Hepatitis A in the EU/EEA: The case for scaling up prevention.

Lara Tavoschi1, Ettore Severi2, Paloma Carrillo Santisteve3, Pierluigi Lopalco4.   

Abstract

Entities:  

Keywords:  Hepatitis A; hepatitis A vaccines; vaccination

Mesh：

Substances：

Year:  2018        PMID： 29628152     DOI： 10.1016/j.vaccine.2018.02.100

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  3 in total

1.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

Review 2.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

3.  High impact of molecular surveillance on hepatitis A outbreak case detection in Sweden: a retrospective study, 2009 to 2018.

Authors:  Maximilian Riess; Theresa Enkirch; Lena Sundqvist; Josefine Lundberg Ederth
Journal:  Euro Surveill       Date:  2021-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.